PolyNovo Keeps Bull After FY Revenue Beat -- Market Talk0124 GMT - PolyNovo keeps its bull at Macquarie after the skin-healing tech developerbeat fiscal 2024 revenue expectations. The investment bank's analysts tell clients in anote that the Australia-listed company's A$104.8 million annual revenue was about 1%stronger than they had anticipated, and about 2% higher than the average analystforecast. They think that fiscal 2024 will turn out to be PolyNovo's first profitableyear, and are looking for an underlying net profit of A$3.7 million. Looking furtherahead, they maintain their forecast of 48% fiscal 2025 sales growth and see recentlylaunched regions including India to grow as a proportion of total sales. Macquarie keepsa A$2.75 target price on the stock, which is up 2.5% at A$2.665.
Ann: FY24 Trading Result (unaudited), page-125
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
-0.070(2.70%) |
Mkt cap ! $1.740B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.61 | $2.47 | $3.489M | 1.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3841 | $2.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.54 | 9238 | 2 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |